A Slippery Slope for Investment Trusts with Wide Discounts

Why It Matters

Discounts erode investor returns and can signal deeper governance or liquidity issues; how trusts address them will shape fund viability and market confidence.

Key Takeaways

• Activist pressure pushes trusts to cut NAV discounts.
• Buybacks shrink fund size, risking long‑term investor value.
• Illiquid asset sales for buybacks may leave junk holdings behind.
• Tenders often benefit activist or institutional shareholders more than retail.
• Structured exit programs can balance discount reduction and fund viability.

Pulse Analysis

The rise of activist investors targeting underperforming investment trusts has forced many boards to confront persistent discounts to net asset value. While activist campaigns can catalyze needed governance reforms, they also expose trusts that have grown complacent about shareholder interests. Reducing the discount is not merely a cosmetic exercise; it directly influences fund pricing, liquidity, and the ability to attract capital in a competitive market. Boards now face a strategic choice: implement substantive operational changes or rely on financial engineering to appease short‑term pressures.

Share buybacks and tender offers have become the go‑to tools for many trusts seeking to narrow the discount gap. However, these actions can unintentionally diminish the fund’s asset base, as illustrated by CT Healthcare (formerly Bellevue Healthcare). The trust’s assets fell from roughly £1 billion (about $1.25 bn) in 2021 to under £300 million ($375 m) by 2025, yet the discount remained stubbornly wide. Shrinking the fund reduces its appeal to institutional investors who favor scale and liquidity, and may force the remaining shareholders to bear a higher proportion of illiquid or lower‑quality holdings. Moreover, financing buybacks by selling the best assets can leave a portfolio laden with junk, further eroding confidence.

A more balanced approach involves designing structured exit mechanisms that trigger only under clear underperformance criteria, such as a five‑year window tied to NAV deviation. This protects long‑term investors while still offering a pathway for activists and institutions to realize value. By aligning buyback programs with genuine discount compression rather than merely reducing share count, trusts can preserve scale, improve liquidity, and ultimately deliver better risk‑adjusted returns. The industry’s shift toward disciplined, transparent discount‑management strategies will likely set the benchmark for future trust governance and investor trust.